Pharmacopolitics : drug regulation in the United States and Germany / by Arthur A. Daemmrich.

Author
Daemmrich, Arthur A. [Browse]
Format
Book
Language
English
Published/​Created
Chapel Hill : University of North Carolina Press, [2004], ©2004.
Description
xiii, 203 pages : illustrations ; 25 cm.

Availability

Copies in the Library

Location Call Number Status Location Service Notes
ReCAP - Remote StorageRA401.A3 D34 2004 Browse related items Request

    Details

    Subject(s)
    Series
    Studies in social medicine. [More in this series]
    Summary note
    "In Pharmaco-politics, Arthur Daemmrich challenges assumptions by comparing drug laws, clinical trials, and systems for monitoring adverse reactions in the United States and Germany, two countries with similarly advanced systems for medical research, testing, and patient care. Daemmrich proposes that divergent "therapeutic cultures" - the interrelationships among governments, patients, the medical profession, and the pharmaceutical industry - underlie national differences and explain variations in pharmaceutical markets and medical care."--BOOK JACKET.
    Bibliographic references
    Includes bibliographical references (p. 181-197) and index.
    Contents
    • 1. Introduction: Medicine, Politics, and Governance
    • 2. Drug Laws and Therapeutic Cultures
    • 3. Clinical Trials from Treatment to Test, 1950-1980
    • 4. Clinical Trials as Test and Therapy, 1980-2000
    • 5. Configuring the Market as a Testing Site
    • 6. Conclusion: International Harmonization and the Future of Drug Regulation
    • App. Research Methods and Case Study Selection.
    Other title(s)
    Drug regulation in the United States and Germany
    ISBN
    0807828440 (cloth : alk. paper)
    LCCN
    2003016296
    OCLC
    52720931
    RCP
    C - S
    Statement on language in description
    Princeton University Library aims to describe library materials in a manner that is respectful to the individuals and communities who create, use, and are represented in the collections we manage. Read more...

    Supplementary Information